about
Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcomeImmune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.Nidovirus transcription: how to make sense...?A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation.Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesis.The stability of the duplex between sense and antisense transcription-regulating sequences is a crucial factor in arterivirus subgenomic mRNA synthesis.Comparison of droplet digital PCR and seminested real-time PCR for quantification of cell-associated HIV-1 RNA.HIV Reservoir: Finding the Right Needles in a Needlestack.Minor Contribution of Chimeric Host-HIV Readthrough Transcripts to the Level of HIV Cell-Associated gag RNA.Regulation of relative abundance of arterivirus subgenomic mRNAs.The latest science from the IAS Towards an HIV Cure Symposium: 16-17 July 2016, Durban, South Africa.What do we measure when we measure cell-associated HIV RNA.Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion[Molecular epidemiology of HIV-1 strains in the Moscow Region]Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremiaModest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasmaCell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ARTDifferences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs
P50
Q33521702-24D574AF-89D5-431E-9C1C-405996EFA9C6Q34292622-AF184F00-5CB6-49E6-9D98-20A3C1FE9413Q36475903-86EFF551-259D-4F54-B219-6463B0B6DCEEQ36736780-DD134E44-7DE2-4EFD-B787-F0008501C59FQ37153174-C3AF97EF-A976-4FE1-B3C6-6C7360C9A6B0Q39437932-A3534131-7FB3-4D22-94CC-6033F75B097BQ39644751-3145E9D8-EAD5-4A75-8536-E580D782F056Q39699246-D1E7D321-CDB7-459C-A26D-55FF8C21A5C5Q40166933-ACEFADEA-04C9-4D14-B86E-D8E564CEA036Q40539090-B98AFA13-A232-40FB-A7CB-39A65684A3D6Q40913399-B8814902-5380-47B3-B04E-A5CF3AA5B854Q41039254-6D8D850E-3F87-4E3A-BEC3-72C99A2B9F92Q42380882-40FCF891-5B86-4DE3-8DF2-119EEAD0779DQ47548192-92ACE739-64D4-4A59-90AD-D7D537E2E4A1Q61796320-51CF7BE4-A5DC-4E98-A080-BE44452E834CQ83282001-4431C646-136E-4B8A-BAE8-AAB00F83391BQ84395550-57359929-7A5E-4867-99C1-341FAA643DFFQ84883831-59B7A368-A2CF-4EE3-854D-1D72EEEA96DCQ89875340-E1C26BCC-7C8C-4D06-9033-FF73CBEF96C7Q94459613-C5C77B6E-2D7A-470D-A918-CC9F74CA24C5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alexander O Pasternak
@en
Alexander O Pasternak
@es
Alexander Pasternak
@nl
type
label
Alexander O Pasternak
@en
Alexander O Pasternak
@es
Alexander Pasternak
@nl
altLabel
A. Pasternak
@nl
A.O. Pasternak
@nl
Alexander O Pasternak
@nl
prefLabel
Alexander O Pasternak
@en
Alexander O Pasternak
@es
Alexander Pasternak
@nl
P106
P31
P496
0000-0002-4097-4251